CMAX Clinical Research Information

Established in 1993, CMAX is one of Australia’s largest, longest running and most experienced, dedicated clinical trial unit. Our team specialises in a range of early-phase clinical trials, including first in human studies – of which we’ve conducted more than 200 to date. With an impressive global regulatory history and a database of more than 50,000 active volunteers, our brand new 78-bed Phase I (through to Phase II-IV) unit is located right in the heard of Adelaide’s Bio-Med City. All of our studies are fully ICH GCP compliant and comply with the registration requirements of the US FDA, EMEA, Japanese MHW and Canadian HPB; we have been US FDA-audited.